$FPAY
FlexShopper, Inc. Stock $fpay

$fpay Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000121390023038510 Filed on May 11, 2023

Income Statement

Concept	2023 Q1	2022 Q1
Revenue	$30.79M	$28.96M
YoY Change	6.32%	-11.67%
Cost Of Revenue	$15.35M	$19.16M
YoY Change	-19.91%	-14.96%
Gross Profit	$15.44M	$9.795M
YoY Change	57.64%	-4.54%
Gross Profit Margin	50.15%	33.83%
Selling, General & Admin	$3.826M	$5.158M
YoY Change	-25.82%	8.82%
% of Gross Profit	24.78%	52.66%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.163M	$20.10M
YoY Change	-94.21%	-8.02%
% of Gross Profit	7.53%	205.19%
Operating Expenses	$11.29M	$11.08M
YoY Change	1.9%	25.17%
Operating Profit	$4.153M	-$1.283M
YoY Change	-423.75%	-190.97%
Interest Expense	$4.531M	-$1.958M
YoY Change	-331.42%	39.86%
% of Operating Profit	109.12%
Other Income/Expense, Net
YoY Change
Pretax Income	-$378.8K	-$3.241M
YoY Change	-88.31%
Income Tax	-$148.5K	-$859.8K
% Of Pretax Income
Net Earnings	-$230.2K	-$2.381M
YoY Change	-90.33%	-192576.56%
Net Earnings / Revenue	-0.75%	-8.22%
Basic Earnings Per Share	-$0.06	-$0.14
Diluted Earnings Per Share	-$0.06	-$110.5K
COMMON SHARES
Basic Shares Outstanding	21.75M shares	21.55M shares
Diluted Shares Outstanding	21.75M shares	21.55M shares

Balance Sheet

Concept	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.862M	$4.320M
YoY Change	128.29%	-31.65%
Cash & Equivalents	$9.862M	$4.320M
Short-Term Investments
Other Short-Term Assets	$29.83M	$37.53M
YoY Change	-20.52%	-6.73%
Inventory
Prepaid Expenses	$2.912M
Receivables	$37.15M	$29.54M
Other Receivables		$7.138M
Total Short-Term Assets	$106.2M	$78.52M
YoY Change	35.2%	36.35%
LONG-TERM ASSETS
Property, Plant & Equipment	$8.677M	$8.424M
YoY Change	3.01%	41.58%
Goodwill
YoY Change
Intangibles	$14.72M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$14.05M	$76.81K
YoY Change	18187.24%	9.73%
Total Long-Term Assets	$38.81M	$8.501M
YoY Change	356.54%	41.44%
TOTAL ASSETS
Total Short-Term Assets	$106.2M	$78.52M
Total Long-Term Assets	$38.81M	$8.501M
Total Assets	$145.0M	$87.03M
YoY Change	66.58%	36.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.843M	$4.817M
YoY Change	-20.21%	53.89%
Accrued Expenses	$2.648M	$2.416M
YoY Change	9.57%	-32.31%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.211M	$233.9K
YoY Change	417.57%	-82.8%
Total Short-Term Liabilities	$8.485M	$7.467M
YoY Change	13.63%	-7.24%
LONG-TERM LIABILITIES
Long-Term Debt	$94.91M	$63.46M
YoY Change	49.55%	52.22%
Other Long-Term Liabilities	$10.35M	$1.715M
YoY Change	503.66%	-17.94%
Total Long-Term Liabilities	$105.3M	$65.18M
YoY Change	61.5%	48.87%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.485M	$7.467M
Total Long-Term Liabilities	$105.3M	$65.18M
Total Liabilities	$113.7M	$72.82M
YoY Change	56.2%	40.47%
SHAREHOLDERS EQUITY
Retained Earnings	-$31.82M
YoY Change
Common Stock	$2.176K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$31.23M	$14.20M
YoY Change
Total Liabilities & Shareholders Equity	$145.0M	$87.03M
YoY Change	66.58%	36.83%

Cashflow Statement

Concept	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$230.2K	-$2.381M
YoY Change	-90.33%	-192576.56%
Depreciation, Depletion And Amortization	$1.163M	$20.10M
YoY Change	-94.21%	-8.02%
Cash From Operating Activities	$5.599M	-$7.941M
YoY Change	-170.51%	1317.98%
INVESTING ACTIVITIES
Capital Expenditures	$1.754M	-$1.554M
YoY Change	-212.87%	112.85%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$1.923M	-$1.554M
YoY Change	23.75%	112.85%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$19.72K	8.720M
YoY Change	-99.77%	-1037.58%
NET CHANGE
Cash From Operating Activities	$5.599M	-7.941M
Cash From Investing Activities	-$1.923M	-1.554M
Cash From Financing Activities	$19.72K	8.720M
Net Change In Cash	$3.696M	-774.9K
YoY Change	-576.96%	-65.09%
FREE CASH FLOW
Cash From Operating Activities	$5.599M	-$7.941M
Capital Expenditures	$1.754M	-$1.554M
Free Cash Flow	$3.846M	-$6.387M
YoY Change	-160.21%	-3856.97%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueGranted		usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue		usd
CY2023Q1	fpay	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod1		shares
CY2023Q1	fpay	Weighted Average Grant Date Fair Value Granted WeightedAverageGrantDateFairValueGranted
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-37945
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	20-5456087
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	901 Yamato Road
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 260
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Boca Raton
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33431
CY2023Q1	dei	City Area Code CityAreaCode	(855)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	353-9289
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	FPAY
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	21752304	shares
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	9861646	usd
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	6051713	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	7881	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	121636	usd
CY2023Q1	fpay	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod1		shares
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	37153935	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35540043	usd
CY2023Q1	us-gaap	Securities Received As Collateral SecuritiesReceivedAsCollateral	29317948	usd
CY2022Q4	us-gaap	Securities Received As Collateral SecuritiesReceivedAsCollateral	32932504	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2912447	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3489136	usd
CY2023Q1	fpay	Lease Merchandise LeaseMerchandise	26908105	usd
CY2022Q4	fpay	Lease Merchandise LeaseMerchandise	31550441	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	106161962	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	109685473	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8677314	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8086862	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1366235	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1406270	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	14719290	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	15162349	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	1884060	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	1934728	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	12162368	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	12013828	usd
CY2023Q1	us-gaap	Assets Assets	144971229	usd
CY2022Q4	us-gaap	Assets Assets	148289510	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3843178	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	6511943	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	565370	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	310820	usd
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	1210806	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	1209455	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2647608	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3988093	usd
CY2023Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	217862	usd
CY2022Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	208001	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	8484824	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	12228312	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	281884	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	352252	usd
CY2023Q1	us-gaap	Long Term Loans Payable LongTermLoansPayable	81093116	usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	80847748	usd
CY2023Q1	fpay	Promissory Notes To Related Parties Net Of Current Portion PromissoryNotesToRelatedPartiesNetOfCurrentPortion	10750000	usd
CY2022Q4	fpay	Promissory Notes To Related Parties Net Of Current Portion PromissoryNotesToRelatedPartiesNetOfCurrentPortion	10750000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	1105789	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	1165027	usd
CY2023Q1	fpay	Promissory Note Related To Acquisition1 PromissoryNoteRelatedToAcquisition1	3063771	usd
CY2022Q4	fpay	Promissory Note Related To Acquisition1 PromissoryNoteRelatedToAcquisition1	3158471	usd
CY2023Q1	us-gaap	Other Notes Payable OtherNotesPayable	8844959	usd
CY2022Q4	us-gaap	Other Notes Payable OtherNotesPayable	8703684	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1508168	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1566622	usd
CY2023Q1	us-gaap	Liabilities Liabilities	113744838	usd
CY2022Q4	us-gaap	Liabilities Liabilities	117254837	usd
CY2023Q1	fpay	Convertible Preferred Stock Series ConvertiblePreferredStockSeries	851660	usd
CY2022Q4	fpay	Convertible Preferred Stock Series ConvertiblePreferredStockSeries	851660	usd
CY2023Q1	fpay	Convertible Preferred Stock Series Two ConvertiblePreferredStockSeriesTwo	21952000	usd
CY2022Q4	fpay	Convertible Preferred Stock Series Two ConvertiblePreferredStockSeriesTwo	21952000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	40000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21752304	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21752304	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	21750804	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	21750804	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	2176	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2176	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	40241353	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	39819420	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-31820798	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-31590583	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	31226391	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	31034673	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	144971229	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	148289510	usd
CY2023Q1	fpay	Lease Revenues And Fees Net LeaseRevenuesAndFeesNet	24714158	usd
CY2022Q1	fpay	Lease Revenues And Fees Net LeaseRevenuesAndFeesNet	27766312	usd
CY2023Q1	fpay	Net Changes In The Fair Value Of Loans Receivable At Fair Value Amount NetChangesInTheFairValueOfLoansReceivableAtFairValueAmount	6071617	usd
CY2022Q1	fpay	Net Changes In The Fair Value Of Loans Receivable At Fair Value Amount NetChangesInTheFairValueOfLoansReceivableAtFairValueAmount	1188924	usd
CY2023Q1	us-gaap	Revenues Revenues	30785775	usd
CY2022Q1	us-gaap	Revenues Revenues	28955236	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	15345788	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	19160611	usd
CY2023Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1833627	usd
CY2022Q1	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	425513	usd
CY2023Q1	us-gaap	Marketing Expense MarketingExpense	1099189	usd
CY2022Q1	us-gaap	Marketing Expense MarketingExpense	2014115	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2726890	usd
CY2022Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2964442	usd
CY2023Q1	us-gaap	Other General Expense OtherGeneralExpense	5627708	usd
CY2022Q1	us-gaap	Other General Expense OtherGeneralExpense	5673202	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	26633202	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	30237883	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	4152573	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1282647	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	4531327	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	1958068	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-378754	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3240715	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-148539	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-859780	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-230215	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2380935	usd
CY2023Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	972233	usd
CY2022Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	609777	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1202448	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2990712	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21751304	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21547069	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21751304	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21547069	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	31034673	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	420748	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1185	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-230215	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	31226391	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	16143619	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	305229	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	137057	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2380935	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	14204970	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-230215	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2380935	usd
CY2023Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	15345788	usd
CY2022Q1	us-gaap	Depreciation Amortization And Accretion Net DepreciationAmortizationAndAccretionNet	19160611	usd
CY2023Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	1826157	usd
CY2022Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	937062	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	70367	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	50603	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	59239	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	420748	usd
CY2023Q1	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod1		shares
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	305229	usd
CY2023Q1	fpay	Provisions For Doubtful Accounts ProvisionsForDoubtfulAccounts	-11238415	usd
CY2022Q1	fpay	Provisions For Doubtful Accounts ProvisionsForDoubtfulAccounts	-11831117	usd
CY2023Q1	fpay	Interest In Kind Added To Promissory Notes Balance InterestInKindAddedToPromissoryNotesBalance	1351	usd
CY2022Q1	fpay	Interest In Kind Added To Promissory Notes Balance InterestInKindAddedToPromissoryNotesBalance	170765	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-148539	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-317006	usd
CY2023Q1	fpay	Net Changes In The Fair Value Of Loans Receivable At Fair Value NetChangesInTheFairValueOfLoansReceivableAtFairValue	-984652	usd
CY2022Q1	fpay	Net Changes In The Fair Value Of Loans Receivable At Fair Value NetChangesInTheFairValueOfLoansReceivableAtFairValue	523424	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	12852307	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	15655280	usd
CY2023Q1	fpay	Increase Decrease In Loans Receivable At Fair Value IncreaseDecreaseInLoansReceivableAtFairValue	-4599208	usd
CY2022Q1	fpay	Increase Decrease In Loans Receivable At Fair Value IncreaseDecreaseInLoansReceivableAtFairValue	4100819	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-576689	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-650764	usd
CY2023Q1	fpay	Increase Decrease In Lease Liability IncreaseDecreaseInLeaseLiability	10703452	usd
CY2022Q1	fpay	Increase Decrease In Lease Liability IncreaseDecreaseInLeaseLiability	14816328	usd
CY2023Q1	fpay	Purchase Consideration Payable Related To Acquisition PurchaseConsiderationPayableRelatedToAcquisition	141275	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-6032	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-2511	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2668765	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3165343	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	254550	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	273946	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1340486	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1405958	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5599339	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7940659	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1753800	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1260755	usd
CY2023Q1	fpay	Purchases Of Data Costs PurchasesOfDataCosts	169082	usd
CY2022Q1	fpay	Purchases Of Data Costs PurchasesOfDataCosts	293055	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1922882	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1553810	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	2750000	usd
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	6800000	usd
CY2023Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	2575000	usd
CY2022Q1	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	1125000	usd
CY2022Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	86931	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1185	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	137057	usd
CY2022Q1	fpay	Proceeds From Debt Instrument ProceedsFromDebtInstrument	3000000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2526	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2796	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	153938	usd
CY2022Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	2802	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19721	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8719528	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3696178	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-774941	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6173349	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	5094642	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9869527	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4319701	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3867982	usd
CY2022Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1679296	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Estimates -</b> The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9861646	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6051713	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	7881	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	121636	usd
CY2023Q1	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	9869527	usd
CY2022Q4	us-gaap	Restricted Cash And Investments Current RestrictedCashAndInvestmentsCurrent	6173349	usd
CY2023Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	42499378	usd
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	48618843	usd
CY2023Q1	fpay	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	5345443	usd
CY2022Q4	fpay	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	13078800	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	37153935	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	35540043	usd
CY2023Q1	fpay	Accounts Receivable Charged Off Against Allowance AccountsReceivableChargedOffAgainstAllowance	18971772	usd
CY2022Q1	fpay	Accounts Receivable Charged Off Against Allowance AccountsReceivableChargedOffAgainstAllowance	17083567	usd
CY2023Q1	fpay	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod1		shares
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	13078800	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	27703278	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	11238415	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	57420480	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	18971772	usd
CY2022	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	72044958	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	5345443	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	13078800	usd
CY2023Q1	fpay	Lease Merchandise At Cost LeaseMerchandiseAtCost	58037072	usd
CY2022Q4	fpay	Lease Merchandise At Cost LeaseMerchandiseAtCost	62379920	usd
CY2023Q1	fpay	Impairment Reserve ImpairmentReserve	31128967	usd
CY2022Q4	fpay	Impairment Reserve ImpairmentReserve	30829479	usd
CY2023Q1	fpay	Lease Merchandise Net LeaseMerchandiseNet	26908105	usd
CY2022Q4	fpay	Lease Merchandise Net LeaseMerchandiseNet	31550441	usd
CY2023Q1	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	984652	usd
CY2023Q1	fpay	Share Based Compensation Arrangement By Share Based Payments Award Equity Instruments Other Than Options Vested In Period1 ShareBasedCompensationArrangementByShareBasedPaymentsAwardEquityInstrumentsOtherThanOptionsVestedInPeriod1		shares
CY2022Q1	us-gaap	Nonoperating Gains Losses NonoperatingGainsLosses	523424	usd
CY2023Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	34255083	usd
CY2022	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	39597429	usd
CY2023Q1	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	11238415	usd
CY2022	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	11831117	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	1697490	usd
CY2023Q1	fpay	Lease Revenues And Fees LeaseRevenuesAndFees	24714158	usd
CY2022	fpay	Lease Revenues And Fees LeaseRevenuesAndFees	27766312	usd
CY2023Q1	fpay	Interest Expense Debt Including Amortization InterestExpenseDebtIncludingAmortization	70367	usd
CY2022Q1	fpay	Interest Expense Debt Including Amortization InterestExpenseDebtIncludingAmortization	49329	usd
CY2023Q1	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	443059	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	769	usd
CY2023Q1	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	1163348	usd
CY2022Q1	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	847572	usd
CY2023Q1	us-gaap	Payments For Software PaymentsForSoftware	1295814	usd
CY2022Q1	us-gaap	Payments For Software PaymentsForSoftware	984994	usd
CY2023Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	909344	usd
CY2022Q1	us-gaap	Capitalized Computer Software Amortization1 CapitalizedComputerSoftwareAmortization1	621694	usd
CY2023Q1	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	169082	usd
CY2022Q1	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	293055	usd
CY2023Q1	fpay	Capitalized Data Costs Amortization Expense CapitalizedDataCostsAmortizationExpense	219750	usd
CY2022Q1	fpay	Capitalized Data Costs Amortization Expense CapitalizedDataCostsAmortizationExpense	88721	usd
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13151068	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13070899	shares
CY2023Q1	fpay	Net Incomelosses NetIncomelosses	230215	usd
CY2022Q1	fpay	Net Incomelosses NetIncomelosses	2380935	usd
CY2023Q1	fpay	Convertible Series2 Preferred Share Dividends ConvertibleSeries2PreferredShareDividends	-972233	usd
CY2022Q1	fpay	Convertible Series2 Preferred Share Dividends ConvertibleSeries2PreferredShareDividends	-609777	usd
CY2023Q1	fpay	Net Incomeloss Attributable To Common Shares After Assumed Conversions Numerator For Diluted Eps NetIncomelossAttributableToCommonSharesAfterAssumedConversionsNumeratorForDilutedEps	-1202448	usd
CY2022Q1	fpay	Net Incomeloss Attributable To Common Shares After Assumed Conversions Numerator For Diluted Eps NetIncomelossAttributableToCommonSharesAfterAssumedConversionsNumeratorForDilutedEps	-2990712	usd
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	21751304	shares
CY2022Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	21547069	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2023Q1	us-gaap	Fair Value Option Loans Held As Assets90 Days Or More Past Due Aggregate Difference FairValueOptionLoansHeldAsAssets90DaysOrMorePastDueAggregateDifference	408738	usd
CY2022Q4	us-gaap	Fair Value Option Loans Held As Assets90 Days Or More Past Due Aggregate Difference FairValueOptionLoansHeldAsAssets90DaysOrMorePastDueAggregateDifference	203182	usd
CY2023Q1	us-gaap	Fair Value Option Loans Held As Assets Aggregate Amount In Nonaccrual Status Aggregated Difference FairValueOptionLoansHeldAsAssetsAggregateAmountInNonaccrualStatusAggregatedDifference	1241540	usd
CY2022Q4	us-gaap	Fair Value Option Loans Held As Assets Aggregate Amount In Nonaccrual Status Aggregated Difference FairValueOptionLoansHeldAsAssetsAggregateAmountInNonaccrualStatusAggregatedDifference	1841812	usd
CY2023Q1	us-gaap	Fair Value Option Loans Held As Assets Aggregate Difference FairValueOptionLoansHeldAsAssetsAggregateDifference	13758820	usd
CY2022Q4	us-gaap	Fair Value Option Loans Held As Assets Aggregate Difference FairValueOptionLoansHeldAsAssetsAggregateDifference	6947224	usd
CY2023Q1	fpay	Largest Benefit Percentage LargestBenefitPercentage	0.50	pure
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	847574	usd
CY2023Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Reclassifications</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain prior year/ period balances have been reclassified to conform with the current year/ period presentation. These reclassifications primarily include separating the prepaid expenses, right of use asset and loan revenues and fees, net of changes in fair value as separate line items. </p>
CY2019Q1	fpay	Term Of Lease TermOfLease	P108M
CY2019Q1	us-gaap	Area Of Land AreaOfLand	21622	sqm
CY2019Q1	fpay	Conversion Of Stock Options Into Common Stock ConversionOfStockOptionsIntoCommonStock	31500	usd
CY2019Q1	us-gaap	Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage	0.03	pure
CY2021Q3	us-gaap	Payments For Rent PaymentsForRent	8800	usd
CY2023Q1	fpay	Operating Leases Rent Expense Monthly Rent OperatingLeasesRentExpenseMonthlyRent	1700	usd
CY2023Q1	fpay	Total Lease Assets TotalLeaseAssets	1366235	usd
CY2022Q4	fpay	Total Lease Assets TotalLeaseAssets	1406270	usd
CY2023Q1	fpay	Total Lease Liabilities TotalLeaseLiabilities	1726030	usd
CY2022Q4	fpay	Total Lease Liabilities TotalLeaseLiabilities	1774623	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	97367	usd
CY2022Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	97592	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	103368	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	100356	usd
CY2023Q1	fpay	Finance Lease Principal Payment FinanceLeasePrincipalPayment	2526	usd
CY2022Q1	fpay	Finance Lease Principal Payment FinanceLeasePrincipalPayment	2796	usd
CY2023Q1	fpay	Operating Lease Future Minimum Payments Due Current OperatingLeaseFutureMinimumPaymentsDueCurrent	314238	usd
CY2023Q1	fpay	Operating Lease Future Minimum Payments Due In Two Years OperatingLeaseFutureMinimumPaymentsDueInTwoYears	430134	usd
CY2023Q1	fpay	Operating Lease Future Minimum Payments Due In Three Years OperatingLeaseFutureMinimumPaymentsDueInThreeYears	443038	usd
CY2023Q1	fpay	Operating Lease Future Minimum Payments Due In Four Years OperatingLeaseFutureMinimumPaymentsDueInFourYears	456330	usd
CY2023Q1	fpay	Operating Lease Future Minimum Payments Due In Five Years OperatingLeaseFutureMinimumPaymentsDueInFiveYears	470019	usd
CY2023Q1	fpay	Operating Lease Future Minimum Payments Due Thereafter OperatingLeaseFutureMinimumPaymentsDueThereafter	303574	usd
CY2023Q1	fpay	Operating Lease Future Minimum Payments Due OperatingLeaseFutureMinimumPaymentsDue	2417333	usd
CY2023Q1	fpay	Interest Interest	-702262	usd
CY2023Q1	fpay	Present Value Of Lease Liabilities PresentValueOfLeaseLiabilities	1715071	usd
CY2023Q1	fpay	Schedule Of Undiscounted Finance Lease Liabilities ScheduleOfUndiscountedFinanceLeaseLiabilities	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><span style="font-size: 10pt"><b>Finance Leases</b></span></td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 89%"><span style="font-size: 10pt">2023</span></td> <td style="width: 1%"> </td> <td style="width: 1%"><span style="font-size: 10pt">$ </span></td> <td style="width: 8%; text-align: right"><span style="font-size: 10pt">7,180</span></td> <td style="width: 1%"> </td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-size: 10pt">2024</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-size: 10pt">4,782</span></td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-size: 10pt">Total undiscounted cash flows</span></td> <td> </td> <td> </td> <td style="text-align: right"><span style="font-size: 10pt">11,962</span></td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td><span style="font-size: 10pt">Less: interest</span></td> <td> </td> <td style="border-bottom: black 1.5pt solid"> </td> <td style="border-bottom: black 1.5pt solid; text-align: right"><span style="font-size: 10pt">(1,003</span></td> <td><span style="font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><span style="font-size: 10pt">Present value of lease liabilities</span></td> <td> </td> <td style="border-bottom: black 4.5pt double"><span style="font-size: 10pt">$</span></td> <td style="border-bottom: black 4.5pt double; text-align: right"><span style="font-size: 10pt">10,959</span></td> <td> </td></tr> </table>
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	7180	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	4782	usd
CY2023Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	11962	usd
CY2023Q1	fpay	Finance Leaseinterest FinanceLeaseinterest	1003	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	10959	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	26363828	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	24610028	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17686514	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16523166	usd
CY2023Q1	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	8677314	usd
CY2022Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	8086862	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1163349	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15338654	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-619364000000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	14719290000000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	15338654	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-176305000000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	15162349000000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	1327980	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1769152	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1748616	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1707544	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1675004	usd
CY2023Q1	fpay	Total Total	8228296	usd
CY2023Q1	fpay	Principal Accrued Unpaid Interestoutstanding PrincipalAccruedUnpaidInterestoutstanding	1017941	usd
CY2022	fpay	Principal Accrued Unpaid Interestoutstanding PrincipalAccruedUnpaidInterestoutstanding	1017826	usd
CY2023Q1	us-gaap	Interest Expense Other InterestExpenseOther	52643	usd
CY2022Q1	us-gaap	Interest Expense Other InterestExpenseOther	32716	usd
CY2023Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	51676	usd
CY2022Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	62529	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	565909	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	151286	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	555522	usd
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	292238	usd
CY2021Q1	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	237000	usd
CY2022Q3	fpay	Loans Percentage LoansPercentage	1	pure
CY2022Q3	fpay	Loans Percentage LoansPercentage	1	pure
CY2023Q1	fpay	Schedule Of Covenant Requirements And Flexshoppers Actual Results ScheduleOfCovenantRequirementsAndFlexshoppersActualResults	<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">March 31, 2023</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Required<br/> Covenant</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Actual <br/> Position</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Equity Book Value not less than</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">16,452,246</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">31,226,391</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Liquidity greater than</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,861,646</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Cash greater than</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">9,869,527</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Consolidated Total Debt to Equity Book Value ratio not to exceed</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5.25</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3.12</td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	fpay	Borrowed Credit Agreement BorrowedCreditAgreement	2750000	usd
CY2022Q1	fpay	Borrowed Credit Agreement BorrowedCreditAgreement	6800000	usd
CY2023Q1	fpay	Repaid Credit Agreement RepaidCreditAgreement	2575000	usd
CY2022Q1	fpay	Repaid Credit Agreement RepaidCreditAgreement	1125000	usd
CY2023Q1	fpay	Credit Agreement Interest Rate CreditAgreementInterestRate	0.04	pure
CY2020Q3	fpay	Warrant Exercise Price WarrantExercisePrice	1.6
CY2020Q3	fpay	Warrants Expiration Period WarrantsExpirationPeriod	P4Y
CY2023Q1	fpay	Warrant Convertible Into Common Stock WarrantConvertibleIntoCommonStock	116903	shares
CY2022Q1	fpay	Warrant Convertible Into Common Stock WarrantConvertibleIntoCommonStock	116903	shares
CY2023Q1	fpay	Stock Options StockOptions	420748	usd
CY2022Q1	fpay	Stock Options StockOptions	291283	usd
CY2022Q1	fpay	Performance Share Units PerformanceShareUnits	-13946	usd
CY2023Q1	fpay	Total Stockbased Compensation TotalStockbasedCompensation	420748	usd
CY2022Q1	fpay	Total Stockbased Compensation TotalStockbasedCompensation	305229	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	420748	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	305229	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	439321	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y1M13D
CY2023Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3919228	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.97
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	52223	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	1500	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.79
CY2023Q1	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedIntrinsicValue	345	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3917728	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.97
CY2023Q1	fpay	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2	P6Y6M14D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	3016	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	3555094	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.98
CY2023Q1	fpay	Sharebased Compensation Arrangement By Sharebased Payment Award Option Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term3 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm3	P6Y5M19D
CY2023Q1	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Aggregate Intrinsic Value1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableAggregateIntrinsicValue1	3016	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3080904	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.06
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1923642	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	951944	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.54
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	162956	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.84
CY2022Q1	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedIntrinsicValue	204030	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	7333	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.22
CY2022Q1	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedIntrinsicValue	2273	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	25000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	1.7
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3837559	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.98
CY2022Q1	fpay	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm2	P7Y4M2D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	925306	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2508822	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.25
CY2022Q1	fpay	Sharebased Compensation Arrangement By Sharebased Payment Award Option Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term3 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm3	P6Y6M29D
CY2022Q1	fpay	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Exercisable Aggregate Intrinsic Value1 ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisableAggregateIntrinsicValue1	731891	usd
CY2023Q1	fpay	Weighted Average Grant Fair Value WeightedAverageGrantFairValue	0
CY2022Q1	fpay	Weighted Average Grant Fair Value WeightedAverageGrantFairValue	0.92
CY2022	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties		usd
CY2023Q1	fpay	Performance Share Units PerformanceShareUnits		usd
CY2022Q4	fpay	Share Based Compensation Arrangement By Shares Based Payment Award Options Vested And Expected To Vest Outstanding Number1 ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber1	790327	shares
CY2023Q1	fpay	Share Based Compensation Arrangement By Shares Based Payments Award Options Vested And Expected To Vest Outstanding Number1 ShareBasedCompensationArrangementBySharesBasedPaymentsAwardOptionsVestedAndExpectedToVestOutstandingNumber1	1.53	shares
CY2023Q1	fpay	Share Based Compensation Arrangement By Shares Based Payment Award Options Vested And Expected To Vest Outstanding Number1 ShareBasedCompensationArrangementBySharesBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber1	790327	shares
CY2023Q1	fpay	Weighted Average Grant Date Fair Value Non Vested1 WeightedAverageGrantDateFairValueNonVested1	P1Y6M10D
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.39	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2023Q1	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>12. CONTINGENCIES AND OTHER UNCERTAINTIES</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Regulatory inquiries</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the first quarter of 2021, FlexShopper, along with a number of other lease-to-own companies, received a subpoena from the California Department of Financial Protection and Innovation (the “DFPI”) requesting the production of documents and information regarding the Company’s compliance with state consumer protection laws. The Company is cooperatively engaging with the DFPI in response to its inquiry. Although the Company believes it is in compliance with all applicable consumer protection laws and regulations in California, this inquiry ultimately could lead to an enforcement action and/or a consent order, and substantial costs, including legal fees, fines, penalties, and remediation expenses.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Litigation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company is not involved in any current or pending material litigation. The Company could be involved in litigation incidental to the operation of the business. The Company intends to vigorously defend all matters in which the Company is named defendants, and, for insurable losses, maintain significant levels of insurance to protect against adverse judgments, claims or assessments that may affect the Company. Although the adequacy of existing insurance coverage of the outcome of any legal proceedings cannot be predicted with certainty, based on the current information available, the Company does not believe the ultimate liability associated with known claims or litigation, if any, in which the Company is involved will materially affect the Company’s consolidated financial condition or results of operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Employment agreements</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain executive management entered into employment agreements with the Company. The contracts are for a period between three to five years and renew for three successive one-year terms unless receipt of written notices by the parties. The contracts provide that such management may earn discretionary cash bonuses and equity awards, based on financial performance metrics defined each year by the Compensation Committee of the Company’s Board of Directors. Additionally, under certain termination conditions, such contracts provide for severance payments and other benefits.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>COVID-19 and other similar health crisis</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has been, and may in the future, be impacted by COVID-19 or any similar pandemic or health crisis, and this could affect our results of operations, financial condition, or cash flow in the future. The extent and the effects of the impact of any of these events on the operation and financial performance of our business depend on several factors which are highly uncertain and cannot be predicted.</p>
CY2023Q1	fpay	Principal Amounts PrincipalAmounts	5000000	usd
CY2023Q1	us-gaap	Investment Maturity Date InvestmentMaturityDate	2027-12-01
CY2023Q1	fpay	Interest Per Annum InterestPerAnnum	0.08	pure
CY2023Q1	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	3421991	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	3063771	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	3158471	usd
CY2023Q1	fpay	Business Combination Bargain Price BusinessCombinationBargainPrice	14461274	usd
CY2023Q1	us-gaap	Multiemployer Plan Pension Significant Employer Contribution Under Collective Bargaining Arrangement To Total Employer Contribution Percentage MultiemployerPlanPensionSignificantEmployerContributionUnderCollectiveBargainingArrangementToTotalEmployerContributionPercentage	0.04	pure
CY2022Q3	us-gaap	Defined Benefit Plan Expected Future Employer Contributions Current Fiscal Year DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear	50161	usd
CY2022Q1	us-gaap	Defined Benefit Plan Expected Future Employer Contributions Current Fiscal Year DefinedBenefitPlanExpectedFutureEmployerContributionsCurrentFiscalYear	50617	usd
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	FlexShopper, Inc.
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2022Q1	fpay	Purchase Consideration Payable Related To Acquisition PurchaseConsiderationPayableRelatedToAcquisition		usd
CY2023Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts		usd
CY2023Q1	fpay	Proceeds From Debt Instrument ProceedsFromDebtInstrument		usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001397047

Files In Submission

Name	View Source	Status
fpay-20230331_def.xml	Edgar Link	unprocessable
0001213900-23-038510-index-headers.html	Edgar Link	pending
0001213900-23-038510-index.html	Edgar Link	pending
0001213900-23-038510.txt	Edgar Link	pending
0001213900-23-038510-xbrl.zip	Edgar Link	pending
f10q0323ex31-1_flexshopper.htm	Edgar Link	pending
f10q0323ex32-1_flexshopper.htm	Edgar Link	pending
f10q0323_flexshopper.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
fpay-20230331.xsd	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
fpay-20230331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
fpay-20230331_pre.xml	Edgar Link	unprocessable
fpay-20230331_lab.xml	Edgar Link	unprocessable
f10q0323_flexshopper_htm.xml	Edgar Link	completed
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$FPAY
FlexShopper, Inc. Stock $fpay

2023 Q1 Form 10-Q Financial Statement

#000121390023038510 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FPAY FlexShopper, Inc. Stock $fpay

2023 Q1 Form 10-Q Financial Statement

#000121390023038510 Filed on May 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$FPAY
FlexShopper, Inc. Stock $fpay